Gingival crevicular fluid osteocalcin, N-terminal telopeptides, and calprotectin levels in cyclosporin A-induced gingival overgrowth. 2011

Sema Becerik, and Ali Gürkan, and Beral Afacan, and Veli Özgen Öztürk, and Harika Atmaca, and Hüseyin Töz, and Gül Atilla, and Gülnur Emingil
Department of Periodontology, School of Dentistry, Ege University, İzmir, Turkey. sema.cinar@ege.edu.tr

BACKGROUND The aim of this cross-sectional study is to investigate gingival crevicular fluid (GCF) osteocalcin, cross-linked N-terminal telopeptide (NTx), and calprotectin levels in cyclosporin A (CsA)-induced gingival overgrowth (GO). METHODS Forty medicated patients with CsA including 20 with GO (CsA GO+), 10 without GO (CsA GO-), 10 with GO and chronic periodontitis (CsA CP) and 60 patients with CP alone, 20 patients with gingivitis, and 20 healthy patients were enrolled. Probing depth, clinical attachment level, plaque index, and papillary bleeding index were recorded. GCF calprotectin, osteocalcin, and NTx levels were analyzed by enzyme-linked immunosorbent assay. Parametric tests were used for statistical analysis. RESULTS The CsA GO+ and CP groups had significantly lower GCF osteocalcin levels and osteocalcin/NTx ratio than the healthy group, whereas GCF osteocalcin levels and osteocalcin/NTx ratio in the gingivitis group were higher than the CsA GO+, CsA GO-, CsA CP, and CP groups (P <0.05). The CP group had elevated GCF calprotectin levels compared to the other study groups (P <0.05). The CsA GO+ and CsA GO- groups also had higher GCF calprotectin levels compared to the CsA CP, gingivitis, and healthy groups (P <0.05). CONCLUSIONS Increased GCF calprotectin and decreased GCF osteocalcin levels in the CsA GO+ and CsA GO- groups might suggest that CsA plays a role on the levels of these markers. The similarity of GCF osteocalcin, NTx, and calprotectin levels in the CsA GO+ and CsA GO- groups might suggest that these molecules are not involved in the pathogenesis of GO.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D005883 Gingival Crevicular Fluid A fluid occurring in minute amounts in the gingival crevice, believed by some authorities to be an inflammatory exudate and by others to cleanse material from the crevice, containing sticky plasma proteins which improve adhesions of the epithelial attachment, have antimicrobial properties, and exert antibody activity. (From Jablonski, Illustrated Dictionary of Dentistry, 1982) Gingival Exudate,Crevicular Fluid, Gingival,Crevicular Fluids, Gingival,Exudate, Gingival,Exudates, Gingival,Fluid, Gingival Crevicular,Fluids, Gingival Crevicular,Gingival Crevicular Fluids,Gingival Exudates
D005891 Gingivitis Inflammation of gum tissue (GINGIVA) without loss of connective tissue. Gingivitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Sema Becerik, and Ali Gürkan, and Beral Afacan, and Veli Özgen Öztürk, and Harika Atmaca, and Hüseyin Töz, and Gül Atilla, and Gülnur Emingil
October 2006, Clinical oral implants research,
Sema Becerik, and Ali Gürkan, and Beral Afacan, and Veli Özgen Öztürk, and Harika Atmaca, and Hüseyin Töz, and Gül Atilla, and Gülnur Emingil
January 2011, Disease markers,
Sema Becerik, and Ali Gürkan, and Beral Afacan, and Veli Özgen Öztürk, and Harika Atmaca, and Hüseyin Töz, and Gül Atilla, and Gülnur Emingil
May 2004, Archives of oral biology,
Sema Becerik, and Ali Gürkan, and Beral Afacan, and Veli Özgen Öztürk, and Harika Atmaca, and Hüseyin Töz, and Gül Atilla, and Gülnur Emingil
June 2011, American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics,
Sema Becerik, and Ali Gürkan, and Beral Afacan, and Veli Özgen Öztürk, and Harika Atmaca, and Hüseyin Töz, and Gül Atilla, and Gülnur Emingil
August 1998, Journal of periodontology,
Sema Becerik, and Ali Gürkan, and Beral Afacan, and Veli Özgen Öztürk, and Harika Atmaca, and Hüseyin Töz, and Gül Atilla, and Gülnur Emingil
April 1999, Journal of clinical periodontology,
Sema Becerik, and Ali Gürkan, and Beral Afacan, and Veli Özgen Öztürk, and Harika Atmaca, and Hüseyin Töz, and Gül Atilla, and Gülnur Emingil
April 2020, Nigerian journal of clinical practice,
Sema Becerik, and Ali Gürkan, and Beral Afacan, and Veli Özgen Öztürk, and Harika Atmaca, and Hüseyin Töz, and Gül Atilla, and Gülnur Emingil
September 1993, Journal of periodontology,
Sema Becerik, and Ali Gürkan, and Beral Afacan, and Veli Özgen Öztürk, and Harika Atmaca, and Hüseyin Töz, and Gül Atilla, and Gülnur Emingil
November 2005, International journal of paediatric dentistry,
Sema Becerik, and Ali Gürkan, and Beral Afacan, and Veli Özgen Öztürk, and Harika Atmaca, and Hüseyin Töz, and Gül Atilla, and Gülnur Emingil
September 1993, Journal of periodontal research,
Copied contents to your clipboard!